Therapeutic effect of iron with vitamin E, vitamin D, and omega-3 supplements in patients with anemia

Study and comparison of the therapeutic effect of iron supplementation with vitamin E, vitamin D, and omega-3 on ferritin levels in three separate groups of patients with iron deficiency anemia.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250922067319N1

Enrollment

Registered

2025-10-29

Start date

2025-12-22

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iron Deficiency Anemia. Iron deficiency anemia, unspecified

Interventions

Intervention 1: Intervention group1: In this group, iron supplements are taken along with vitamin E supplements. The dosage of vitamin E (produced by Sina Daru Company)is 200 units for children under

Eligibility

Sex/Gender

All

Age

2 Years to 18 Years

Inclusion criteria

Inclusion criteria: Patients with iron deficiency anemia (IDA)

Exclusion criteria

Exclusion criteria: The presence of concomitant infectious and inflammatory diseases The presence of other causes of anemia besides iron deficiency Previous use of supplements used in the plan in the last 3 months The presence of digestive problems in the patient, such as malabsorption or irritable bowel syndrome Taking antibiotics in the last few months

Design outcomes

Primary

Measure	Time frame
Ferritin. Timepoint: 3 months after drug administration. Method of measurement: ELISA method.	—

Secondary

Measure	Time frame
Mean Corpuscular Volume (MCV). Timepoint: 3 months after drug administration. Method of measurement: ELISA method.;Mean Corpuscular Hemoglobin (MCH). Timepoint: 3 months after drug administration. Method of measurement: ELISA method.;Red Cell Distribution Width (RDW). Timepoint: 3 months after drug administration. Method of measurement: ELISA method.;Retic. Timepoint: 3 months after drug administration. Method of measurement: ELISA method.	—

Measure

Time frame

Mean Corpuscular Volume (MCV). Timepoint: 3 months after drug administration. Method of measurement: ELISA method.;Mean Corpuscular Hemoglobin (MCH). Timepoint: 3 months after drug administration. Method of measurement: ELISA method.;Red Cell Distribution Width (RDW). Timepoint: 3 months after drug administration. Method of measurement: ELISA method.;Retic. Timepoint: 3 months after drug administration. Method of measurement: ELISA method.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryamalsadat Yazdanparast

Yazd University of Medical Sciences

m.yazdanparast@ssu.ac.ir+98 35 3183 4264

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026